NonWoTecc Medical
A technology company specializing in developing nanotechnology-based coatings and coverings for medical devices, including occluders, stents and vascular grafts.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor | €0.0 | round | |
N/A | Acquisition | ||
| Total Funding | 000k | ||
| EUR | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 |
|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
NonWoTecc Medical GmbH is a Cologne-based medical technology firm focused on developing and producing artificial vascular prostheses. The company's core technology revolves around the specialized processing of polycarbonate urethane (PCU), a biocompatible high-performance polymer, through a patented manufacturing method. This process is applied to create small-lumen vascular grafts intended for use in coronary and peripheral bypass procedures, serving as replacements for the body's own vessels when they are blocked.
The firm specializes in creating nanotechnology-based coatings and coverings for a range of medical devices, including occluders, stents, and vascular grafts. This positions the company within the cardiovascular device market, specifically targeting interventional cardiology. Its business model appears centered on research and development with the goal of commercializing its coating technology and launching its vascular prosthesis products, likely through sales to hospitals and other medical facilities that perform cardiovascular surgeries.
Since its inception around 2011, NonWoTecc Medical has secured significant financing to advance its product development and market entry strategies. A notable milestone was the completion of a €7 million second financing round, with contributions from investors such as NRW.BANK, Rheinland Venture Capital, Kreissparkasse Köln, High-Tech Gründerfonds, and KfW. This capital was earmarked for obtaining product approval, launching its vascular prostheses, expanding its production capabilities, and furthering the commercialization of its coating technology. The company's intellectual property includes patents for devices used for placement in hollow organs and for structures with adhesively bonded fibers.
Keywords: medical technology, vascular prostheses, polycarbonate urethane, cardiovascular devices, interventional cardiology, nanotechnology coatings, medical device manufacturing, coronary bypass, peripheral bypass, biocompatible polymers, small-lumen grafts, vascular grafts, medical device financing, medtech, life sciences, healthcare innovation, surgical devices, artificial blood vessels, implantable devices, medical polymers